Exporter India Xovoltib 40mg (Afatinib Dimaleate)| Bulk Supply Oncology Drugs .
Buy Xovoltib 40mg (Afatinib Dimaleate) in bulk from India. Leading oncology drug exporter City Drug House Exporters offering global supply with latest regulatory updates and competitive pricing.
Mechanism of Action :
Xovoltib 40mg acts as a potent and irreversible inhibitor of the ErbB family of receptors.
It works by Irreversible Binding: Forming covalent bonds with EGFR (HER1), HER2, and HER4 receptor tyrosine kinases, leading to permanent shutting down of their activity.
Downregulation of Signaling: Blocking the signaling pathways that cause cancer cells to multiply and grow.
Apoptosis Induction: Inducing programmed cell death in tumor cells.
Key Therapeutic Indications
First-line treatment: Patients with metastatic NSCLC whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations.
Second-line treatment: Advanced squamous NSCLC progressing after platinum-based chemotherapy.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Buy Xovoltib 40mg (Afatinib Dimaleate) in bulk from India. Leading oncology drug exporter City Drug House Exporters offering global supply with latest regulatory updates and competitive pricing.
Mechanism of Action :
Xovoltib 40mg acts as a potent and irreversible inhibitor of the ErbB family of receptors.
It works by Irreversible Binding: Forming covalent bonds with EGFR (HER1), HER2, and HER4 receptor tyrosine kinases, leading to permanent shutting down of their activity.
Downregulation of Signaling: Blocking the signaling pathways that cause cancer cells to multiply and grow.
Apoptosis Induction: Inducing programmed cell death in tumor cells.
Key Therapeutic Indications
First-line treatment: Patients with metastatic NSCLC whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations.
Second-line treatment: Advanced squamous NSCLC progressing after platinum-based chemotherapy.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
